Vol.
30
No.
40
October 22, 2004Oct 22, 2004
Free

As patients worry about COX-2 inhibitors, scientists and FDA review toxicity data.

Also in this 8-page issue: M.D. Anderson Cancer Center wins ninth SPORE grant, this time for melanoma research.

Fox Chase Cancer Center plans $1 billion expansion that would double its size.

Human Genome Project publishes its final product.

Login